Abstract The National Institutes of Health (NIH) recognizes that, despite HIV scientific
advances, stigma and discrimination continue to be critical barriers to the uptake of evidence …

Patient safety is fundamental to the provision of health care in all settings. However,
avoidable adverse events, errors and risks associated with health care remain major …

Antiretroviral therapy (ART) allows suppressed viremia to reach less than 50 copies/mL in
most treated persons living with HIV (PLWH). However, the existence of PLWH that show …

Background Contemporary antiretroviral therapies (ART) and management strategies have
diminished both human immunodeficiency virus (HIV) treatment failure and the acquired …

To inform the level of attention to be given by antiretroviral therapy (ART) programs to HIV
drug resistance (HIVDR), we used an individual-level model to estimate its impact on future …

Introduction HIV‐1 transmitted drug resistance (TDR) prevalence increased during the initial
years of the antiretroviral therapy (ART) global scale‐up. Few studies have examined recent …

Background There is concern over increasing prevalence of non-nucleoside reverse-
transcriptase inhibitor (NNRTI) resistance in people initiating antiretroviral therapy (ART) in …

Introduction: Routinely monitoring the HIV viral load (VL) of people living with HIV (PLHIV)
on anti-retroviral therapy (ART) facilitates intensive adherence counselling and faster ART …

Epidemiology of HIV drug resistance in low- and middle-incom... : Current Opinion in HIV and
AIDS Epidemiology of HIV drug resistance in low- and middle-income countries and WHO …

Background The presence of high-abundance drug-resistant HIV-1 jeopardizes success of
antiretroviral therapy (ART). Despite numerous investigations, the clinical impact of low …